Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of HPC, Cord Blood

NCT03735277 is registered in ClinicalTrials.gov with BHI Therapeutic Sciences as lead sponsor.

NCT NCT03735277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03735277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of HPC, Cord Blood
Lead sponsor
BHI Therapeutic Sciences
Phase
Phase 1
Overall status
Unknown status
Start date
March 6, 2021
Completion date
July 31, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke